Jundishapur Journal of Microbiology

Published by: Kowsar

Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital

Mo Guo-xin 1 , She Dan-yang 1 , Guan Xi-zhou 1 , Cui Jun-chang 1 , Wang Rui 2 , Cui Zhi-gang 3 and Chen Liang-an 1 , *
Authors Information
1 Department of Respiratory Disease, Chinese PLA General Hospital, Beijing, China
2 Institutes of Clinical Pharmacology Chinese, PLA General Hospital, Beijing, China
3 State Key Laboratory for Communicable Diseases, Prevention and Control Institute of Communicable Disease Prevention and Control Chinese Center for Disease Control and Prevention, Beijing, China
Article information
  • Jundishapur Journal of Microbiology: January 01, 2014, 7 (1); e13120
  • Published Online: January 1, 2014
  • Article Type: Brief Report
  • Received: June 22, 2013
  • Revised: October 7, 2013
  • Accepted: November 18, 2013
  • DOI: 10.5812/jjm.13120

To Cite: Guo-xin M, Dan-yang S, Xi-zhou G, Jun-chang C, Rui W, et al. Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital, Jundishapur J Microbiol. 2014 ; 7(1):e13120. doi: 10.5812/jjm.13120.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Karageorgopoulos Drosos E, Falagas Matthew E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008; 8(12): 751-762[DOI]
  • 2. Chan JZ, Halachev MR, Loman NJ, Constantinidou C, Pallen MJ. Defining bacterial species in the genomic era: insights from the genus Acinetobacter. BMC Microbiol. 2012; 12: 302[DOI][PubMed]
  • 3. Cetin ES, Durmaz R, Tetik T, Otlu B, Kaya S, Caliskan A. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis. Am J Infect Control. 2009; 37(1): 56-64[DOI][PubMed]
  • 4. Amudhan SM, Sekar U, Arunagiri K, Sekar B. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian J Med Microbiol. 2011; 29(3): 269-74[DOI][PubMed]
  • 5. Jeong SH, Bae IK, Park KO, An YJ, Sohn SG, Jang SJ, et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol. 2006; 44(4): 423-31[PubMed]
  • 6. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis. 2003; 36(10): 1268-74[DOI][PubMed]
  • 7. Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol. 2007; 45(2): 453-60[DOI][PubMed]
  • 8. Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect. 1991; 19(3): 191-200[DOI]
  • 9. Livermore DM, Hill RL, Thomson H, Charlett A, Turton JF, Pike R, et al. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int J Antimicrob Agents. 2010; 35(1): 19-24[DOI][PubMed]
  • 10. Webster C, Towner KJ, Humphreys H. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol. 2000; 21(4): 246[DOI][PubMed]
  • 11. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997; 35(11): 2819-25[PubMed]
  • 12. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006; 44(8): 2974-6[DOI][PubMed]
  • 13. Ocana V, Silva C, Nader-Macias ME. Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. Infect Dis Obstet Gynecol. 2006; 2006: 18182[DOI][PubMed]
  • 14. Uete G, Matsuo K, Uete T. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test]. Jpn J Antibiot. 1992; 45(5): 489-501[PubMed]
  • 15. Rocha LA, Martin MJ, Pita S, Paz J, Seco C, Margusino L, et al. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study. Intensive Care Med. 1992; 18(7): 398-404[PubMed]
  • 16. Cefai C, Richards J, Gould FK, McPeake P. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect. 1990; 15(2): 177-182[DOI]
  • 17. Sherertz RJ, Sullivan ML. An Outbreak of Infections with Acinetobacter calcoaceticus in Burn Patients: Contamination of Patients' Mattresses. J Infect Dis. 1985; 151(2): 252-258[DOI]
  • 18. Weernink A, Severin WPJ, Tjernberg I, Dijkshoorn L. Pillows, an unexpected source of Acinetobacter. J Hosp Infect. 1995; 29(3): 189-199[DOI]
  • 19. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest. 1999; 115(5): 1378-82[PubMed]
  • 20. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9(2): 148-65[PubMed]
  • 21. Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987; 317(1): 18-22[DOI][PubMed]
  • 22. Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med. 1994; 20(3): 193-8[PubMed]
  • 23. Zimmerman S, Gruber-Baldini AL, Hebel JR, Sloane PD, Magaziner J. Nursing home facility risk factors for infection and hospitalization: importance of registered nurse turnover, administration, and social factors. J Am Geriatr Soc. 2002; 50(12): 1987-95[PubMed]
  • 24. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990; 142(3): 523-8[DOI][PubMed]
  • 25. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005; 40(9): 1333-41[DOI][PubMed]
  • 26. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis. 2002; 8(8): 827-32[DOI][PubMed]
  • 27. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007; 59(4): 772-4[DOI][PubMed]
  • 28. Young LS, Sabel AL, Price CS. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2007; 28(11): 1247-54[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments